Evidence map›Paper›PMID 27026410›Full record

ArticleBMC research notes2016

Prevalence of human immunodeficiency virus infection in a cohort of tuberculosis patients at Metema Hospital, Northwest Ethiopia: a 3 years retrospective study.

Daniel Tarekegne, Muhabaw Jemal, Tadesse Atanaw, Ashenafi Ebabu, Mengistu Endris, Feleke Moges, Belay Tessema, Tekalign Deressa

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC research notes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Heliyon · 2024
    Article
  10. Article
  11. Detection ofTuberculosis research and treatment · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Trends ofTropical diseases, travel medicine and vaccines · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Daniel TarekegneSchool of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Muhabaw JemalSchool of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Tadesse AtanawSchool of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Ashenafi EbabuSchool of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Mengistu EndrisSchool of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Feleke MogesSchool of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Belay TessemaSchool of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Tekalign DeressaSchool of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia. tekalign09@gmail.com.
University of Gondar · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEthiopia is one of the countries that are highly affected by dual epidemics of human immunodeficiency virus (HIV) and tuberculosis (TB). HIV infection is a known risk factor for the development of active TB and it challenges in diagnosis and treatment of TB. Thus, it is essential to determine the epidemiology of HIV infection among TB patients to guide clinical actions and inform the policy makers. This study was aimed to assess the prevalence of HIV infection among TB patients and to describe the associated risk factors for HIV seropositivity.

methodsA retrospective study was conducted on TB registries at Metema Hospital directly observed therapy short-course (DOTS) clinic. Binary and multivariate logistic regression analysis was used to determine the association of HIV seropositivity among TB patients. Odds ratio (OR) and 95% confidence intervals (CI) were calculated. P value less than 0.05 was considered as statistically significant.

resultsOf the total 2096 patients, 2005 (95.7%) were tested for HIV. The overall HIV-TB co-infection rate was 20.1% (404), 12.3% (246) in males and 7.9% (158) in females. The highest proportion of co-infection rate was observed among the patients in the age group of 25-34 years (32.4%) and smear negative pulmonary TB patients (59.7%). A declining trend of HIV-TB co-infection was observed during the study period, from 22.1% (185) in 2009/10 to 12.8% (52) in 2011/12 (X(2) = 17.07, P < 0.001).

conclusionsThis study found that HIV-TB co-infection is still high in the Metema area; and occurs more frequently in males than females, and among patients in age group of 25-34 years. Thus, concerted efforts and interventions methods that target these at risk groups are recommended.

Indexed as

AdolescentAdultAgedChildChild, PreschoolCohort StudiesCoinfectionDemographyEthiopiaFemaleHIV InfectionsHumansInfantInfant, NewbornMaleMiddle AgedCo-infectionHIVMetemaNorthwest EthiopiaTrendsTuberculosis

Identifiers

PMID27026410
PMCPMC4810509
OpenAlexW2325920210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.